2Montalescot G,Ankri A,Chadefaux-Vekemans B,et al.Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease[J].Int J Cardiol,1999,60(3):295-300.
3Piccirllo G.Power spectral analysis of HR in elderly hypertensive subjects with and without silent coronary disease[J].Angiology,2008,7(1):15-17.
4Gottsater A,Ahlgren AR,Taimour S,et al.Decreased heart rate variability may prediot the progression of carotid atherosclerosis in type 2 diabetes[J].Clin Auton Res,2006,16(3):288-234.
5Malinow MR,Bostom AG,Krauss RM.Homocysteine,diet and cardiovascular diseases:a statement for healthcare professionals from the Nutrition Committee,American Heart Association[J].Circulation,1999,99(1):178-182.
6Hofmann MA,Kohl B,Zumbach MS,et al.Hyperhomocystinemia and endothelial dysfunction in IDDM1[J].Diabetes Care,1998,21 (6):1028-1030.
7Chico VA,Mudaliar S,Schmidt B,et al.Homocysteine associated with diabetes[J].Metabolism,2008,47 (6):685-689.
8Hoogeveen EK,Kostense PJ,Beks PJ,et al.Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease,especially in noninsulin-dependent diabetes mellitus:a populationbased study[J].Arterioscler Thromb Vascular Biol,1998,18(1):133-138.
9Passaro A,D'elia K,Pareschi PL,et al.Factors influencing plasma homocysteine levels in type 2 diabetes[J].Diabetes Care,2000,23(3):420-421.
10Malik M.Heart rate variability:standards of measurement,physiology interoretation,and clinical use[J].Circulation,1996,93(5):1043-1065.
